Study identifier:NIS-GSE-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A prospective, non interventional study to evaluate the effects on quality of life, symptoms and productivity in patients with gastroesophageal reflux disease (GERD) after 6 weeks structured treatment in a company health care setting
GERD
-
No
-
All
36
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|